UT Health San Antonio Offers New MS in Imaging Sciences

UT Health San Antonio Offers New MS in Imaging Sciences

The School of Health Professions at the University of Texas Health Science Center at San Antonio (UT Health San Antonio) recently announced its plan to introduce the first Master of Science in Imaging Sciences. The program offers training for imaging technologists in radiography, computed tomography (CT), and magnetic resonance imaging (MRI). According to program director…

Read More

Only 5.8% of People Eligible Receive Lung Cancer Screening

Only 5.8% of People Eligible Receive Lung Cancer Screening

The American Lung Association’s 5th annual “State of Lung Cancer” revealed that only 5.8% of the Americans eligible for low-dose CT lung cancer screening had been screened. The US Preventive Services Task Force guidelines recommendations are: Have a 20-pack-year history (1 pack/day for 20 years, 2 packs/day for 10 years) Are a current smoker or…

Read More

FDA Approves GE’s DaTscan to Detect Dementia with Lewy Bodies

FDA Approves GE's DaTscan to Detect Dementia with Lewy Bodies

GE Healthcare announced on November 3 that patients suspected of having Dementia with Lewy Bodies (DLB) now have new FDA-approved imaging options to diagnose DLB definitely. This kind of dementia is sometimes called LBD or Lewy Body Dementia. GE’s DaTscan (ioflupane I 123) has been used to confirm a diagnosis of Parkinson’s disease in over…

Read More

ACR Launches Contrast-Enhanced Mammography Screening Trial for Women with Dense Breasts

ACR Launches Contrast-Enhanced Mammography Screening Trial for Women with Dense Breasts

The American College of Radiology (ACR), in collaboration with the Breast Cancer Research Foundation (BCRF) and GE Healthcare, is about to launch the Contrast-Enhanced Mammography Imaging Screening Trial (CMIST). The trial aims to ascertain whether contrast-enhanced mammography increases breast cancer detection and lowers false positives in women with dense breasts. Dense breasts account for 43%…

Read More

The Future of Amyloid-fighting Drugs Alzheimer’s Disease and Radiology

The Future of Amyloid-fighting Drugs Alzheimer's Disease and Radiology

In the next few years, expect amyloid-fighting drugs to treat Alzheimer’s disease to be an emerging category of more commonly-used monoclonal antibodies. Researchers, led by Petrice Cogswell, MD, PhD, of the Mayo Clinic, recommend that both neuroradiologists and general radiologists become familiar with the treatment-related side effects caused by amyloid-related imaging abnormalities (ARIAs). The researchers’…

Read More